Search results
AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence
Zacks via Yahoo News· 1 week agoAbbVie's (ABBV) acquisition of Celsius Therapeutics is set to add the latter's lead pipeline...
Here's Why You Should Consider Buying Alvotech (ALVO) Stock
Zacks via Yahoo News· 2 weeks agoAlvotech ALVO makes biosimilar versions of branded medicines that have gone off-patent. The year...
Exelixis (EXEL) Settles Cabometyx Patent Litigation With Cipla
Zacks via Yahoo News· 1 month agoExelixis (EXEL) resolves two patent litigations and grants Cipla a license to market generic...
Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?
Zacks via Yahoo News· 2 months agoThe Medical group has plenty of great stocks, but investors should always be looking for companies...
Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?
Zacks via Yahoo News· 2 months agoHere at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and...
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
Zacks via Yahoo News· 2 months agoTEVA reports mixed first-quarter results, missing estimates for earnings but beating the same for...
Teva Pharmaceutical Industries (TEVA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks via Yahoo News· 2 months agoAlthough the revenue and EPS for Teva Pharmaceutical Industries (TEVA) give a sense of how its...
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Zacks via Yahoo News· 2 months agoThe earnings season for the drug/biotech sector is now in its final lap, with two S&P 500 companies,...
Unlocking Q1 Potential of Teva Pharmaceutical Industries (TEVA): Exploring Wall Street Estimates for...
Zacks via Yahoo News· 2 months agoEvaluate the expected performance of Teva Pharmaceutical Industries (TEVA) for the quarter ended...
Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo News· 2 months agoOn Vanda's (VNDA) first-quarter 2024 earnings call, investors' focus is likely to be on the sales...